BeStock  
Stocks › Biotechnology › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #706Biotechnology
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–

ROIV Stock News

Headlines matching Roivant Sciences or the ROIV ticker, most recent first.

  • H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $47Market news · 9 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $46 to $55Market news · 9 Sep 2026 · Direct mention
  • Bernstein Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $41Market news · 27 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41 PositiveMarket news · 2 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy RatingMarket news · 18 Sep 2026 · Direct mention
  • Stifel Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $51Market news · 17 Sep 2026 · Direct mention
  • Stifel Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $51Market news · 17 Sep 2026 · Direct mention
  • TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $55Market news · 10 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41 PositiveMarket news · 7 Aug 2026 · Direct mention
  • TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40Market news · 28 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $41Market news · 28 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40Market news · 10 Aug 2026 · Direct mention
  • Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46 PositiveMarket news · 10 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ROIV.

Sign in to join the discussion.

Scroll to Top